RNA-Based Therapies Back In Spotlight As Chinese Biotechs Raise $366m

 
• By Dexter Jie Yan

Four Chinese RNA technology developers, including Rona Therapeutics and METiS Pharmaceuticals, have bagged the most proceeds in recent financing rounds in the country backed by venture capital and private equity funds.

fund raising
Investors reignited interest in Chinese biotechs focused on nucleic acid therapeutics • Source: Alamy

More from China

More from Focus On Asia